Article Type
Article
Changed
Thu, 12/15/2022 - 15:14
Display Headline
Clinical Benefits in Patients With Psoriasis After Efalizumab Therapy: Clinical Trials Versus Practice
Author(s)
Ricardo RR
Rhoa M
Orenberg EK
Li N
Rundle AC
Caro I

Article PDF
074030193.pdf
Author and Disclosure Information

Ricardo RR, Rhoa M, Orenberg EK, Li N, Rundle AC, Caro I

Issue
Cutis - 74(3)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Page Number
193-200
Sections
Original Research
Clinical Topics & News
Author(s)
Ricardo RR
Rhoa M
Orenberg EK
Li N
Rundle AC
Caro I
Author(s)
Ricardo RR
Rhoa M
Orenberg EK
Li N
Rundle AC
Caro I
Author and Disclosure Information

Ricardo RR, Rhoa M, Orenberg EK, Li N, Rundle AC, Caro I

Author and Disclosure Information

Ricardo RR, Rhoa M, Orenberg EK, Li N, Rundle AC, Caro I

Article PDF
074030193.pdf
Article PDF
074030193.pdf

Issue
Cutis - 74(3)
Issue
Cutis - 74(3)
Page Number
193-200
Page Number
193-200
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Article
Display Headline
Clinical Benefits in Patients With Psoriasis After Efalizumab Therapy: Clinical Trials Versus Practice
Display Headline
Clinical Benefits in Patients With Psoriasis After Efalizumab Therapy: Clinical Trials Versus Practice
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media